ARCHIVES

NCI Raises New Questions About Duke Genomics Research, Cuts Assay From Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 18 | May 14, 2010

Download PDF Visit The Full Archive

Related Articles

NTP Panel Completed To Write New Testing, Evolution Guidelines

April 22, 1983

NCI/NTP Studies Found EDB Carcinogenic, But Risk To Human Said Not Conclusive

March 23, 1984

Gulf Health Study Begun With $10 Million Each from NIH, BP

September 24, 2010

Lilly Suspends Phase III Trial Of Tasisulam in Melanoma

January 28, 2011

IOM Report Links Agent Orange, CLL

January 24, 2003

NCAB Asks NCI To Delay Proposed change In Breast Cancer Screening Guidelines

November 26, 1993